TY  - JOUR
AU  - Garcia-Pinel, Beatriz
AU  - Jabalera, Ylenia
AU  - Ortiz, Raul
AU  - Cabeza, Laura
AU  - Jimenez-Lopez, Concepción
AU  - Melguizo, Consolación
AU  - Prados, Jose
PY  - 2020
DO  - 10.3390/pharmaceutics12060589
SN  - 1999-4923
UR  - https://hdl.handle.net/10668/28100
T2  - Pharmaceutics
AB  - Current chemotherapy for colorectal cancer (CRC) includes the use of oxaliplatin (Oxa), a first-line cytotoxic drug which, in combination with irinotecan/5-fluorouracil or biologic agents, increases the survival rate of patients. However, the...
LA  - en
KW  - Biomimetics
KW  - Oxaliplatin
KW  - colon carcinoma
KW  - liposome
KW  - nanoparticles
TI  - Biomimetic Magnetoliposomes as Oxaliplatin Nanocarriers: In Vitro Study for Potential Application in Colon Cancer.
TY  - research article
VL  - 12
ER  -